The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citigroup And Goldman Downgrade Property Firms

Fri, 25th Jan 2019 09:47

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and late Thursday:----------FTSE 100----------GOLDMAN RAISES LAND SECURITIES TO 'NEUTRAL' ('SELL') - TARGET 769 (788) PENCE----------CITIGROUP CUTS LAND SECURITIES TO 'SELL' ('NEUTRAL') - TARGET 743 (974) PENCE----------GOLDMAN CUTS BRITISH LAND PRICE TARGET TO 589 (620) PENCE - 'NEUTRAL'----------CITIGROUP CUTS BRITISH LAND TO 'SELL' ('NEUTRAL') - TARGET 452 (647) PENCE----------GOLDMAN CUTS SEGRO PRICE TARGET TO 701 (716) PENCE - 'BUY'----------SOCGEN CUTS ITV TO 'HOLD' ('BUY') - TARGET 138 (190) PENCE----------SHORE CAPITAL RAISES ASTRAZENECA TO 'BUY' ('HOLD')----------HSBC SEES GLAXOSMITHKLINE AS ONE OF THE BEST GLOBAL STOCK IDEAS----------RBC CUTS BHP GROUP PRICE TARGET TO 1500 (1525) PENCE - 'SECTOR PERFORM'----------HSBC RAISES ANGLO AMERICAN PRICE TARGET TO 2120 (2100) PENCE - 'BUY'----------UBS RAISES FRESNILLO TO 'BUY' ('NEUTRAL') - TARGET 1100 (900) PENCE----------JPMORGAN CUTS KINGFISHER PRICE TARGET TO 200 (220) PENCE - 'UNDERWEIGHT'----------GOLDMAN RAISES AB FOODS PRICE TARGET TO 2600 (2500) PENCE - 'NEUTRAL'----------GOLDMAN RAISES SEVERN TRENT PRICE TARGET TO 1847 (1763) PENCE - 'SELL'----------BERNSTEIN CUTS VODAFONE PRICE TARGET TO 225 (235) PENCE - 'OUTPERFORM'----------JPMORGAN CUTS VODAFONE PRICE TARGET TO 230 (240) PENCE - 'OVERWEIGHT'----------DEUTSCHE BANK CUTS ST JAMES'S PLACE PRICE TARGET TO 1070 (1090) PENCE - 'HOLD'----------CREDIT SUISSE CUTS RBS PRICE TARGET TO 280 (295) PENCE - 'NEUTRAL'----------CREDIT SUISSE CUTS LLOYDS PRICE TARGET TO 84 (90) PENCE - 'OUTPERFORM'----------CREDIT SUISSE CUTS BARCLAYS PRICE TARGET TO 190 (210) PENCE - 'NEUTRAL'----------EXANE BNP RAISES HALMA TO 'OUTPERFORM' ('NEUTRAL') - TARGET 1550 (1350) PENCE----------EXANE BNP CUTS SPIRAX-SARCO TO 'UNDERPERFORM' (N) - TARGET 5700 (6300) PENCE----------FTSE 250----------GOLDMAN CUTS INTU PROPERTIES TO 'SELL' ('NEUTRAL') - TARGET 92 (117) PENCE----------CITIGROUP CUTS INTU PROPERTIES TO 'SELL' ('NEUTRAL') - TARGET 69 (190) PENCE----------CITIGROUP CUTS HAMMERSON TO 'SELL' ('NEUTRAL') - TARGET 278 (465) PENCE----------GOLDMAN CUTS HAMMERSON PRICE TARGET TO 367 (441) PENCE - 'NEUTRAL'----------CITIGROUP CUTS GREAT PORTLAND TO 'SELL' ('NEUTRAL') - TARGET 592 (691) PENCE----------GOLDMAN CUTS GREAT PORTLAND PRICE TARGET TO 633 (662) PENCE - 'NEUTRAL'----------GOLDMAN CUTS DERWENT LONDON PRICE TARGET TO 2960 (2976) PENCE - 'NEUTRAL'----------CITIGROUP CUTS DERWENT LONDON TO 'SELL' ('NEUTRAL') - TARGET 2513 (3186) PENCE----------GOLDMAN CUTS SHAFTESBURY PRICE TARGET TO 748 (806) PENCE - 'SELL'----------CITIGROUP CUTS SHAFTESBURY TO 'NEUTRAL' ('BUY') - TARGET 872 (1229) PENCE----------GOLDMAN CUTS BIG YELLOW GROUP PRICE TARGET TO 972 (993) PENCE - 'NEUTRAL'----------UBS CUTS CAPITAL & COUNTIES PRICE TARGET TO 310 (320) PENCE - 'BUY'----------JPMORGAN CUTS TRAVIS PERKINS PRICE TARGET TO 1330 (1400) PENCE - 'NEUTRAL'----------HSBC INITIATES CRANSWICK WITH 'HOLD' - TARGET 2810 PENCE----------HSBC INITIATES DAIRY CREST GROUP WITH 'BUY' - TARGET 570 PENCE----------HSBC INITIATES GREENCORE WITH 'BUY' - TARGET 270 PENCE----------HSBC INITIATES HILTON FOOD WITH 'HOLD' - TARGET 920 PENCE----------EXANE BNP RAISES PHOENIX GROUP TARGET TO 800 PENCE - 'OUTPERFORM'----------UBS CUTS SOPHOS PRICE TARGET TO 400 (440) PENCE - 'BUY'----------LIBERUM RESUMES RESTAURANT GROUP WITH 'HOLD' - TARGET 180 PENCE----------EXANE BNP CUTS SPECTRIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2350 (2550) PENCE----------OTHER MAIN MARKET AND AIM----------CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 685 (770) PENCE - 'NEUTRAL'---------BARCLAYS CUTS DAILY MAIL PRICE TARGET TO 570 (605) PENCE - 'UNDERWEIGHT'----------GOLDMAN CUTS SECURE INCOME REIT PRICE TARGET TO 417 (446) PENCE - 'BUY'----------RBC CUTS FEVERTREE DRINKS PRICE TARGET TO 3400 (3600) PENCE - 'OUTPERFORM'----------DEUTSCHE BANK RAISES FEVERTREE DRINKS TARGET TO 2800 (2700) PENCE - 'HOLD'----------BERENBERG RAISES CONNECT GROUP PRICE TARGET TO 40 (35) PENCE - 'HOLD'----------LIBERUM RESUMES BURFORD CAPITAL WITH 'BUY' - TARGET 2300 PENCE----------

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.